CORRECTION OF HYPERPLASTIC PROCESSES IN ENDOMETRY IN WOMEN OF FERTILE AGE WITH METABOLIC disorders
Aim: to study the efficiency of Depo-Provera - the analogue of natural hestagenis - didrogesterone in women of fertile age with hyperplastic processes in endometrium and metabolic disorders. Methods. Efficiency of hestagenii is studied in 112 patients with hyperplastic processes in endometrium, possessing expressed metabolic disorders, alongside with the evaluation of dynamic changes of body mass, morphologic status of endometrium, hormone and metabolic prophiles. Depo-Provera was prescribed for 39,3% patients, didrogesterone - for 60,7%. Results. The differentiated analysis of mucous uterus status against reception of hestagenii has shown that 52,9% patients receiving didrogesterone and 27,3% who recieved Depo-Provera developed secretory endometrial transformations. Conclusion. The results of the researches have shown that the Depo-Provera renders more expressed antiproliferative effect up to an atrophy of endometrium.